Daglig administration af filgrastim bør fortsætte, indtil det forventede neutrofilnadir passeres, og neutrofiltallet atter ligger inden for normalområdet.
Daily dosing with filgrastim should continue until the expected neutrophil nadir is passed and the neutrophil count has recovered to the normal range.